hkIs36

Caenorhabditis elegans

[dsh-2::DSH-2(del*EP)::GFP]

hkIs38

Caenorhabditis elegans

[dsh-2::DSH-2(del*EP)::GFP]

sdz-26

Caenorhabditis elegans

Expressed in E; Ea; and Ep.

hkIs35

Caenorhabditis elegans

[dsh-2::DSH-2(del*EP)::GFP]

sdz-1

Caenorhabditis elegans

Involved in mesendoderm development. Expressed in several structures, including E; Ea; Ep; MSpa; and somatic gonad precursor.

sdz-31

Caenorhabditis elegans

Involved in gastrulation. Predicted to be located in membrane. Expressed in several structures, including E; Ea; Ep; MSaa; and MSpa.

nit-1

Caenorhabditis elegans

Predicted to enable hydro-lyase activity and nitrilase activity. Expressed in several structures, including E; Ea; Ep; MSaa; and MSpa.

gid-2

Caenorhabditis elegans

Predicted to contribute to ubiquitin-protein transferase activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be located in cytoplasm and nucleus. Predicted to be part of GID complex. Expressed in E; Ea; and Ep. Is an ortholog of human RMND5A (required for meiotic nuclear division 5 homolog A).

B0228.7

Caenorhabditis elegans

Predicted to enable S-methyl-5-thioadenosine phosphorylase activity. Predicted to be involved in L-methionine salvage from methylthioadenosine. Predicted to be located in cytosol. Expressed in Ea and Ep. Human ortholog(s) of this gene implicated in common bile duct neoplasm; diaphyseal medullary stenosis with malignant fibrous histiocytoma; and pancreatic cancer. Is an ortholog of human MTAP (methylthioadenosine phosphorylase).

TX796

Caenorhabditis elegans